GKOS - Glaukos Corp logo

GKOS

Glaukos Corp

Glaukos Corporation develops therapies and devices for glaucoma, corneal disorders, and retinal diseases, including micro-bypass stents and drug delivery systems. It sells products primarily to ambulatory surgery centers, hospitals, and physician practices.

โš•๏ธ Healthcare NYSE Listed 2015 $ USD
$1,000 invested 10 years ago โ†’$5,535today

Score Overview

1 Year
Score
Net Growth-0.19%
Net TrendShrank
Net Income Consistencyโ€”
Rev Growth20.77%
Rev TrendGrew
Revenue Consistencyโ€”
5 Years
Score2.5
Net Growth-279.18%
Net TrendNever
Net Income Consistencyโ€”
Rev Growth108.44%
Rev Trend80%
Revenue Consistencyโ€”
10 Years
Score
Net Growth-41x
Net Trend20%
Net Income Consistency
Rev Growth435.71%
Rev Trend80%
Revenue Consistency
All Time
Score
Net Growth-404.95%
Net Trend27%
Net Income Consistency
Rev Growth8x
Rev Trend82%
Revenue Consistency

See the full market ranking โ†’

Glaukos Corp fundamental performance

Between 2020 and 2025, revenue grew from $ 224M to $ 507M and net income went from -$ 120M to -$ 187M. Revenue increased in 4 of those 5 years; net income in 0.

Across Glaukos Corp's full reported history, from 2015 to 2025, revenue grew from $ 71M to $ 507M and net income went from -$ 37M to -$ 187M. Revenue increased in 82% of the years measured; net income in 27%.

Glaukos Corp currently holds a 5-year HDB Score of 2.5 out of 10. How the HDB Score is calculated.

Net Income x Stock Price

Historical Returns

Historical Returns
PeriodPriceReturn
Last Price2026-08-12
$ 186.63โ€”
1 Year2025-08-12
$ 89.34108.90%
5 Years2021-08-12
$ 49.55276.65%
10 Years2016-08-12
$ 33.72453.47%
All Time2015-06-25
$ 31.22497.79%

Prices are split & dividend adjusted. All values are reported in USD.

Fundamental Data

Year
2026$ 612M-$ 188M$ 286M
2025$ 507M-$ 187M$ 278M
2024$ 383M-$ 146M$ 318M
2023$ 314M-$ 134M$ 295M
2022$ 282M-$ 99M$ 352M
2021$ 294M-$ 49M$ 414M
2020$ 224M-$ 120M$ 404M
2019$ 236M$ 15M$ 173M
2018$ 181M-$ 12M$ 140M
2017$ 159M-$ 92K$ 119M
2016$ 114M$ 4M$ 95M
IPO2015$ 71M-$ 37M$ 91M

Explore beyond GKOS

You're looking at Glaukos Corp. Members apply the same fundamental framework across all 3,860 companies we cover.

$99/year $149 founding price

Unlock Holder Dashboard

30-day money-back guarantee.

Explore other companies